Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Luca Hegedüs"'
Autor:
Luca Hegedüs, Kata D. Szücs, Matthias Kudla, Julian Heidenreich, Verena Jendrossek, Samuel Peña-Llopis, Tamas Garay, Andras Czirok, Clemens Aigner, Till Plönes, Silvia Vega-Rubin-de-Celis, Balazs Hegedüs
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 10 (2022)
Malignant pleural mesothelioma (MPM) is a rare type of cancer with a grim prognosis. So far, no targetable oncogenic mutation was identified in MPM and biomarkers with predictive value toward drug sensitivity or resistance are also lacking. Nintedani
Externí odkaz:
https://doaj.org/article/bdcebd8073a4423daa0b8b32f489f9af
Autor:
Luca Hegedüs, Rita Padányi, Judit Molnár, Katalin Pászty, Karolina Varga, István Kenessey, Eszter Sárközy, Matthias Wolf, Michael Grusch, Zoltán Hegyi, László Homolya, Clemens Aigner, Tamás Garay, Balázs Hegedüs, József Tímár, Enikö Kállay, Ágnes Enyedi
Publikováno v:
Frontiers in Oncology, Vol 7 (2017)
Several new therapeutic options emerged recently to treat metastatic melanoma; however, the high frequency of intrinsic and acquired resistance among patients shows a need for new therapeutic options. Previously, we identified the plasma membrane Ca2
Externí odkaz:
https://doaj.org/article/5a9a973d5cf6496382250ee896690605
Autor:
Luca Hegedüs, Özlem Okumus, Fabian Mairinger, Till Ploenes, Sebastian Reuter, Martin Schuler, Anja Welt, Silvia Vega-Rubin-de-Celis, Dirk Theegarten, Agnes Bankfalvi, Clemens Aigner, Balazs Hegedüs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52ccff928351d619aa170815fc17c694
https://www.ncbi.nlm.nih.gov/pubmed/36907051
https://www.ncbi.nlm.nih.gov/pubmed/36907051
Autor:
Luca Hegedüs, Elisabeth Livingstone, Ágnes Bánkfalvi, Jan Viehof, Ágnes Enyedi, Ágnes Bilecz, Balázs Győrffy, Marcell Baranyi, Anna-Mária Tőkés, Jeovanis Gil, György Marko-Varga, Klaus G. Griewank, Lisa Zimmer, Renáta Váraljai, Antje Sucker, Anne Zaremba, Dirk Schadendorf, Clemens Aigner, Balázs Hegedüs
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 6; Pages: 3324
OA Förderung 2022 PMCA4 is a critical regulator of Ca2+ homeostasis in mammalian cells. While its biological and prognostic relevance in several cancer types has already been demonstrated, only preclinical investigations suggested a metastasis suppr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46f04f4c32a2bb75b6e29c8bbfbd6c9d
Publikováno v:
Journal of cellular physiology. 216(2)
We are interested in two aspects of a given type of metastatic breast cancer: which potentially cancer-relevant genes are expressed and which factors determine invasiveness. Using reverse transcription real-time PCR, we detected gene expression of 26
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb35c1113d55d374bbcf33c367c7776e
https://pubmed.ncbi.nlm.nih.gov/18286480
https://pubmed.ncbi.nlm.nih.gov/18286480
Autor:
Karolina Varga, Anna Hollósi, Katalin Pászty, Luca Hegedűs, Gergely Szakács, József Tímár, Béla Papp, Ágnes Enyedi, Rita Padányi
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-17 (2018)
Abstract Background Remodeling of Ca2+ signaling is an important step in cancer progression, and altered expression of members of the Ca2+ signaling toolkit including the plasma membrane Ca2+ ATPases (PMCA proteins encoded by ATP2B genes) is common i
Externí odkaz:
https://doaj.org/article/874151123680404c81771e4031fd706d
Autor:
Randa Naffa, Lisa Vogel, Luca Hegedűs, Katalin Pászty, Sarolta Tóth, Kornélia Kelemen, Neha Singh, Attila Reményi, Enikő Kállay, Mihály Cserepes, József Tóvári, Michael Grusch, Ágnes Enyedi
Publikováno v:
Cells, Vol 9, Iss 5, p 1209 (2020)
Metastatic melanoma is the most aggressive type of skin cancer. Previously, we identified the plasma membrane Ca2+ pump isoform 4b (PMCA4b or ATP2B4) as a putative metastasis suppressor in BRAF mutant melanoma cells. Metastasis suppressors are often
Externí odkaz:
https://doaj.org/article/94fa8bca835147719b519ff54ca79239